Pharma Stocks Soar Amid Medicaid Cuts and Trump’s Price Pressure — Here’s Why
Amanda Chu of POLITICO reveals how lawmakers are betting millions on pharma stocks even as Trump threatens tariffs and demands steep drug price cuts. Watch!
More Videos
The Job Market’s Next Chapter: Where Workers Are Still in Demand
Kory Kantenga, Head of Economics, Americas at LinkedIn, breaks down hiring trends, labor-market resilience and where employers are still seeking workers.
AI Investing Takes Off: Why Younger Investors Are Turning to AI for Research
Bret Kenwell, U.S. Investment and Options Analyst at eToro, breaks down how younger investors are using AI and where they’re looking beyond Big Tech.
Why Americans Are Spending More on Hobbies Despite Economic Pressure
Joe Wadford, Economist at Bank of America, breaks down the hobby spending boom, “funflation” and why millennials and Gen Z spend differently.
Vanessa Hudgens’ Next Big Role? Building a Cactus Water Brand
Vanessa Hudgens and Oliver Trevena, co-founders of Caliwater, reveal why they’re betting on cactus water, the rise of healthy beverages and plans to grow bigger
Is The Stock Market Rally Running On Borrowed Time?
Adam Turnquist, Chief Cross-Asset Strategist at LPL Financial, breaks down why stocks remain near records despite higher oil prices, rates and Fed tightening.
Graco Turns 100: How Its Industrial Tech Is Powering the AI Boom
Graco CEO Mark Sheahan explains how the 100-year-old company is expanding into AI infrastructure, data centers and advanced manufacturing.
What Exactly Can Meta’s Muse Do And Where Should We Draw the Line?
Christopher Zara, News Director at Fast Company, explains what Meta’s Muse can actually do and whether its growing access to our lives goes too far.
The CLARITY Act Stalled: What Does It Mean For Crypto Investors?
Ryan Louvar, Chief Policy Officer and Head of Business and Legal Affairs, Digital Assets at WisdomTree, breaks down the CLARITY Act and crypto’s next phase.
